Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-05

Clinical Trial Update: Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients

View source ↗

Summary

A clinical trial update indicates Xueshuantong Injection (Lyophilized) is being studied for prevention of venous thromboembolism in hospitalized patients, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xueshuantong Injection (Lyophilized) (Xueshuantong lyophilized injection)

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Venous Thromboembolism (VTE), Thromboembolism | Status: ACTIVE_NOT_RECRUITING